Clinical Trial Update: Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ANT-1403 for primary axillary hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis

Drugs mentioned

• ANT-1403

Snippet

Sponsor: Anterios Inc. | Conditions: Primary Axillary Hyperhidrosis | Phase 2 | Status: COMPLETED